Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC vs LIA for Pain After Total Knee Arthroplasty
NCT02603900Phase 4Withdrawn
- Sponsor
- Thomas Jefferson University
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection, bupivacaine hydrochloride 0.75% injection in acute pain, postoperative pain, sponsored by Thomas Jefferson University. Planned start Oct 2015; status: withdrawn.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionbupivacaine hydrochloride 0.75% injection
03
Conditions
acute painpostoperative pain
Beyond the preview
Go deeper on NCT02603900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603900.